çè·åž«
å»çã«é©åœãèµ·ãã: å»çã«ãããå€§èŠæš¡èšèªã¢ãã«ã®åœ±é¿ãšå°æ¥ãæ¢ã

å»åŠããã³ãã«ã¹ã±ã¢ã«ãããå€§èŠæš¡èšèªã¢ãã« (LLM) ã®çµ±åãšå¿çšã¯ã倧ããªé¢å¿ãšéçºã®ããŒããšãªã£ãŠããŸãã
ãŸãã å»çæ å ±ç®¡çã·ã¹ãã åŠäŒäžçäŒè° ããã®ä»ã®æ³šç®ãã¹ãã€ãã³ãã«ãããŠãGoogle ã®ãããªäŒæ¥ã¯ããã«ã¹ã±ã¢åéã«ãããçæ AI ã®å¯èœæ§ãæ¢ãå é ã«ç«ã£ãŠåãçµãã§ããŸãã Med-PaLM 2 ãªã©ã®åœŒãã®åãçµã¿ã¯ãç¹ã«èšºæãæ£è ã±ã¢ã管çå¹çãªã©ã®åéã«ããã AI äž»å°ã®ãã«ã¹ã±ã¢ ãœãªã¥ãŒã·ã§ã³ã®é²åããç¶æ³ãæµ®ã圫ãã«ããŠããŸãã
ãã«ã¹ã±ã¢åéã®å é§ç㪠LLM ã§ãã Google ã® Med-PaLM 2 ã¯ãåªããæ©èœãå®èšŒããç¹ã«ç±³åœå»åž«å 蚱詊éšåœ¢åŒã®åé¡ã§ããšãã¹ããŒããã¬ãã«ãéæããŸããã ãã®ã¢ãã«ãåæ§ã®ã¢ãã«ã¯ãå»çåŸäºè ãæ å ±ã«ã¢ã¯ã»ã¹ããŠæŽ»çšããæ¹æ³ã«é©åœãããããã蚺æã®ç²ŸåºŠãšæ£è ã±ã¢ã®å¹çãåäžãããå¯èœæ§ããããŸãã
ãããããããã®é²æ©ã«äŒŽããèšåºçŸå Žã«ããããããã®æè¡ã®å®çšæ§ãšå®å šæ§ã«ã€ããŠã®æžå¿µãçããŠããŸãã ããšãã°ãã¢ãã«ã®ãã¬ãŒãã³ã°ã«ãããèšå€§ãªã€ã³ã¿ãŒããã ããŒã¿ ãœãŒã¹ãžã®äŸåã¯ãç¶æ³ã«ãã£ãŠã¯æçã§ãããå»çç®çã«ã¯å¿ ãããé©åãŸãã¯ä¿¡é Œã§ãããšã¯éããŸããã ãšã㊠ãã¬ã ã»ã·ã£ãŒãå士å·ãMBBSãããŒã ããŒã¿ ãµã€ãšã³ãã£ã¹ã ã¹ã¿ã³ãã©ãŒããã«ã¹ã±ã¢ã¯ãåãã¹ãéèŠãªçåã¯ãçŸå®ã®å»ççŸå Žã«ããããããã®ã¢ãã«ã®ããã©ãŒãã³ã¹ãšãæ£è ã±ã¢ãšå»çå¹çã«å¯Ÿãããããã®å®éã®åœ±é¿ã«ã€ããŠã§ãããšææããŠããŸãã
ã·ã£ãŒå士ã®èŠç¹ã¯ãå»çã«ããã LLM ã®å©çšã«å¯Ÿãããããã«ã¹ã¿ãã€ãºãããã¢ãããŒãã®å¿ èŠæ§ã匷調ããŠããŸãã 圌ã¯ãåºç¯ãªã€ã³ã¿ãŒããã ããŒã¿ã§ãã¬ãŒãã³ã°ãããæ±çšã¢ãã«ã®ä»£ããã«ãç¹å®ã®é¢é£ããå»çããŒã¿ã§ã¢ãã«ããã¬ãŒãã³ã°ãããããçŠç¹ãçµã£ãæŠç¥ãææ¡ããŠããŸãã ãã®ã¢ãããŒãã¯ãç ä¿®å»ã®ãã¬ãŒãã³ã°ã«äŒŒãŠããŸããç ä¿®å»ã«ç¹å®ã®ã¿ã¹ã¯ãäžãããã®ããã©ãŒãã³ã¹ãç£ç£ããèœåãçºæ®ããã«ã€ããŠåŸã ã«èªäž»æ§ãé«ããŠãããŸãã
ããã«äŒŽãã EPFL ç ç©¶è ã«ãã Meditron ãã®åéã§è峿·±ã鲿©ã瀺ããŠããŸãã Meditron ã¯ãå»çã¢ããªã±ãŒã·ã§ã³åãã«ç¹å¥ã«èª¿æŽããããªãŒãã³ãœãŒã¹ LLM ã§ããã倧ããªåé²ãšãªããŸãã PubMed ãèšåºã¬ã€ãã©ã€ã³ãªã©ã®ä¿¡é Œã§ããæ å ±æºããå³éžãããå»çããŒã¿ã«åºã¥ããŠãã¬ãŒãã³ã°ããã Meditron ã¯ãããçŠç¹ãçµã£ããããä¿¡é Œæ§ã®é«ãããŒã«ãå»çåŸäºè ã«æäŸããŸãã ãã®ãªãŒãã³ãœãŒã¹ã®æ§è³ªã«ãããéææ§ãšã³ã©ãã¬ãŒã·ã§ã³ãä¿é²ãããã ãã§ãªããããåºç¯ãªç ç©¶ã³ãã¥ããã£ã«ããç¶ç¶çãªæ¹åãšã¹ãã¬ã¹ ãã¹ããå¯èœã«ãªããŸãã

MEDITRON-70B ã¯ãMedQA-70.2 ãªãã·ã§ã³ ããŒã¿ã»ããã® USMLE ã¹ã¿ã€ã«ã®è³ªåã§ 4 ã®ç²ŸåºŠãéæ
MeditronãMed-PaLM 2 ãªã©ã®ããŒã«ã®éçºã¯ãAI ã¢ããªã±ãŒã·ã§ã³ã«é¢ããŠãã«ã¹ã±ã¢åéç¹æã®èŠä»¶ã«å¯Ÿããèªèã®é«ãŸããåæ ããŠããŸãã é¢é£ããé«å質ã®å»çããŒã¿ã«åºã¥ããŠãããã®ã¢ãã«ããã¬ãŒãã³ã°ããèšåºçŸå Žã§ã®å®å šæ§ãšä¿¡é Œæ§ã確ä¿ããããšã«éç¹ã眮ãããšãéåžžã«éèŠã§ãã
ããã«ãèµ€åååœéå§å¡äŒã®ãããªäººéçæèããã®ãã®ãªã©ã倿§ãªããŒã¿ã»ãããå«ãŸããŠããããšã¯ãäžçã®å»çã«ãããããŸããŸãªããŒãºã課é¡ã«ææã§ããããšã瀺ããŠããŸãã ãã®ã¢ãããŒãã¯ãæè¡çã«é²æ©ããŠããã ãã§ãªãã瀟äŒçã«è²¬ä»»ãããæç㪠AI ããŒã«ãäœæããããšãç®çãšããå€ãã® AI ç ç©¶ã»ã³ã¿ãŒã®åºç¯ãªäœ¿åœãšäžèŽããŠããŸãã
ãããšããã¿ã€ãã«ã®è«æå€§èŠæš¡ãªèšèªã¢ãã«ã¯èšåºç¥èããšã³ã³ãŒãããŸããã¯æè¿ Nature ã«æ²èŒãããèšåºçŸå Žã§å€§èŠæš¡èšèªã¢ãã« (LLM) ã广çã«å©çšããæ¹æ³ãæ€èšããŠããŸãã ãã®ç ç©¶ã¯ç»æçãªæŽå¯ã𿹿³è«ãæç€ºããå»çåéã«ããã LLM ã®æ©èœãšéçãæããã«ããŠããŸãã
å»çé åã¯ãèšå€§ãªæ°ã®çç¶ãçŸæ£ãæ²»çæ³ãçµ¶ããé²åããŠããããã®è€éããç¹åŸŽã§ãã LLM ã¯ããã®è€éããçè§£ããã ãã§ãªããææ°ã®å»åŠç¥èãšã¬ã€ãã©ã€ã³ãåžžã«ææ¡ããŠããå¿ èŠããããŸãã
ãã®ç ç©¶ã®äžæ žã¯ãMultiMedQA ãšåŒã°ããæ°ããå³éžããããã³ãããŒã¯ãäžå¿ã«å±éãããŸãã ãã®ãã³ãããŒã¯ã¯ãXNUMX ã€ã®æ¢åã®å»ç質ååçããŒã¿ã»ãããšããªã³ã©ã€ã³ã§é »ç¹ã«æ€çŽ¢ãããå»ç質åã§æ§æãããæ°ããããŒã¿ã»ãã HealthSearchQA ãçµ±åããŠããŸãã ãã®å æ¬çãªã¢ãããŒãã¯ãäºå®æ§ãçè§£åãæšè«ãå±å®³ã®å¯èœæ§ãåèŠãªã©ã®ããŸããŸãªåŽé¢ã«ããã£ãŠ LLM ãè©äŸ¡ããããšãç®çãšããŠãããããã«ãããéããããã³ãããŒã¯ã«äŸåããŠãã以åã®èªåè©äŸ¡ã®éçã«å¯ŸåŠããŸãã
ãã®ç ç©¶ã®éµãšãªãã®ã¯ã540 åãã©ã¡ãŒã¿ã® LLM ã§ãã Pathways Language Model (PaLM) ãšããã®åœä»€èª¿æŽåã§ãã Flan-PaLM ã MultiMedQA äžã§è©äŸ¡ããããšã§ãã æ³šç®ãã¹ãããšã«ãFlan-PaLM ã¯ãç±³åœå»åž«å 蚱詊éšåœ¢åŒã®è³ªåã§æ§æããã MedQA ã§ã® 67.6% ã®ç²ŸåºŠãå«ããMultiMedQA å ã®ãã¹ãŠã®å€è¢éžæããŒã¿ã»ããã§æå 端ã®ç²ŸåºŠãéæããŠããŸãã ãã®ããã©ãŒãã³ã¹ã¯ä»¥åã®ã¢ãã«ã«æ¯ã¹ãŠå€§å¹ ã«åäžããŠãããåŸæ¥ã®æå 端æè¡ã 17% 以äžäžåã£ãŠããŸãã
MedQA
Format: question and answer (Q + A), multiple choice, open domain.
Example question: A 65-year-old man with hypertension comes to the physician for a routine health maintenance examination. Current medications include atenolol, lisinopril, and atorvastatin. His pulse is 86âminâ1, respirations are 18âminâ1, and blood pressure is 145/95âmmHg. Cardiac examination reveals end diastolic murmur. Which of the following is the most likely cause of this physical examination?
Answers (correct answer in bold): (A) Decreased compliance of the left ventricle, (B) Myxomatous degeneration of the mitral valve (C) Inflammation of the pericardium (D) Dilation of the aortic root (E) Thickening of the mitral valve leaflets.
ãã®ç ç©¶ã§ã¯ãç¹ã«æ¶è²»è ã®å»åŠç質åãžã®åçã«ãããŠãã¢ãã«ã®ããã©ãŒãã³ã¹ã«ãããé倧ãªã®ã£ãããç¹å®ããŠããŸãã ãããã®åé¡ã«å¯ŸåŠããããã«ãç ç©¶è ãã¯åœä»€ããã³ãããã¥ãŒãã³ã°ãšããŠç¥ãããæ¹æ³ãå°å ¥ããŸããã ãã®ææ³ã¯ãå°æ°ã®ãµã³ãã«ã䜿çšã㊠LLM ãæ°ãããã¡ã€ã³ã«å¹ççã«èª¿æŽããMed-PaLM ãäœæããŸãã Med-PaLM ã¢ãã«ã¯ææãªããã©ãŒãã³ã¹ã瀺ããçè§£åãç¥èã®æ³èµ·ãæšè«ã®åäžã瀺ããŠããŸãããèšåºå»ãšæ¯èŒãããšãŸã äžååã§ãã
ãã®ç ç©¶ã®æ³šç®ãã¹ãç¹ã¯ã人éã«ãã詳现ãªè©äŸ¡ãã¬ãŒã ã¯ãŒã¯ã§ãã ãã®ãã¬ãŒã ã¯ãŒã¯ã¯ãã¢ãã«ã®åçãç§åŠçåæãšäžèŽããŠãããã©ãããããã³æœåšçãªæå®³ãªçµæã«ã€ããŠè©äŸ¡ããŸãã ããšãã°ãFlan-PaLM ã®é·æåçã®ãã¡ç§åŠçã³ã³ã»ã³ãµã¹ãšäžèŽããã®ã¯ 61.9% ã®ã¿ã§ããããMed-PaLM ã§ã¯ãã®æ°å㯠92.6% ã«äžæããèšåºå»ãäœæããåçãšåçã§ããã åæ§ã«ãæå®³ãªè»¢åž°ã®å¯èœæ§ã¯ãFlan-PaLM ãšæ¯èŒã㊠Med-PaLM ã®åå¿ã§å€§å¹ ã«æžå°ããŸããã
Med-PaLM ã®åçã«å¯Ÿãã人éã«ããè©äŸ¡ã¯ãèšåºå»ãäœæããåçãšå¯æ¥ã«äžèŽãããããã€ãã®åéã«ããã Med-PaLM ã®ç緎床ã匷調ããŸããã ããã¯ãèšåºçŸå Žã«ãããæ¯æŽããŒã«ãšããŠã® Med-PaLM ã®å¯èœæ§ã匷調ããŠããŸãã
äžã§èª¬æããç ç©¶ã§ã¯ãå»çã¢ããªã±ãŒã·ã§ã³åãã®å€§èŠæš¡èšèªã¢ãã« (LLM) ã®åŒ·åã®è€éããæãäžããŠããŸãã ãã®ç ç©¶ã§åŸãããææ³ãšèгå¯çµæã¯ãããŸããŸãªãã¡ã€ã³ã«ããã£ãŠ LLM æ©èœãåäžãããããã«äžè¬åã§ããŸãã 以äžã®éèŠãªåŽé¢ãèŠãŠã¿ãŸãããã
åœä»€ãã¥ãŒãã³ã°ã«ããããã©ãŒãã³ã¹ã®åäž
- äžè¬åãããã¢ããªã±ãŒã·ã§ã³: ç¹å®ã®åœä»€ãã¬ã€ãã©ã€ã³ã䜿çšã㊠LLM ã埮調æŽããåœä»€ãã¥ãŒãã³ã°ã¯ãããŸããŸãªãã¡ã€ã³å šäœã§ããã©ãŒãã³ã¹ãå€§å¹ ã«åäžãããããšã瀺ãããŠããŸãã ãã®ææ³ã¯ãæ³åŸã財åãæè²ãªã©ã®ä»ã®åéã«é©çšããŠãLLM åºåã®ç²ŸåºŠãšé¢é£æ§ãé«ããããšãã§ããŸãã
ã¢ãã«ãµã€ãºã®ã¹ã±ãŒãªã³ã°
- ããåºãæå³: ã¢ãã« ãµã€ãºãã¹ã±ãŒãªã³ã°ãããšããã©ãŒãã³ã¹ãåäžãããšãã芳å¯ã¯ãå»ç質åå¿çã«éå®ãããŸããã ããå€ãã®ãã©ã¡ãŒã¿ãŒãåããå€§èŠæš¡ãªã¢ãã«ã«ã¯ããã埮åŠã§è€éãªå¿çãåŠçããã³çæããèœåããããŸãã ãã®ã¹ã±ãŒãªã³ã°ã¯ã埮åŠãªçè§£ãšå¿çã®çæãéèŠã§ããã«ã¹ã¿ã㌠ãµãŒãã¹ãã¯ãªãšã€ãã£ã ã©ã€ãã£ã³ã°ããã¯ãã«ã« ãµããŒããªã©ã®åéã§æçã§ãã
æèé£é (COT) ããã³ãã
- 倿§ãªãã¡ã€ã³æŽ»çš: COT ããã³ããã®äœ¿çšã¯ãå»çããŒã¿ã»ããã®ããã©ãŒãã³ã¹ãå¿ ãããåäžãããããã§ã¯ãããŸããããè€éãªåé¡è§£æ±ºãå¿ èŠãªä»ã®é åã§ã¯æçã§ãã ããšãã°ãæè¡çãªãã©ãã«ã·ã¥ãŒãã£ã³ã°ãè€éãªæææ±ºå®ã®ã·ããªãªã§ã¯ãCOT ããã³ããã«ãã£ãŠ LLM ãæ®µéçã«æ å ±ãåŠçã§ããããã«ãªããããæ£ç¢ºã§è«ççãªåºåãåŸãããŸãã
èªå·±äžè²«æ§ã«ãã粟床ã®åäž
- ããå¹ åºãçšé: è€æ°ã®åºåãçæãããæãäžè²«æ§ã®ããçããéžæãããèªå·±äžè²«æ§ã®ææ³ã¯ãããŸããŸãªåéã§ããã©ãŒãã³ã¹ãå€§å¹ ã«åäžãããããšãã§ããŸãã æ£ç¢ºæ§ãæåªå ãããéèãæ³åãªã©ã®åéã§ã¯ããã®æ¹æ³ã䜿çšããŠãçæãããåºåãçžäºæ€èšŒããŠä¿¡é Œæ§ãé«ããããšãã§ããŸãã
äžç¢ºå®æ§ãšéžæçäºæž¬
- ã¯ãã¹ãã¡ã€ã³ã®é¢é£æ§ïŒå»çãæ³åŸãªã©ã誀ã£ãæ å ±ãé倧ãªçµæãããããå¯èœæ§ãããåéã§ã¯ãäžç¢ºå®æ§ã®æšå®å€ãäŒéããããšãéåžžã«éèŠã§ãã äžç¢ºå®æ§ã衚çŸããä¿¡é Œæ§ãäœãå Žåã«äºæž¬ãéžæçã«å»¶æãã LLM ã®æ©èœãå©çšããããšã¯ããããã®åéã«ãããŠäžæ£ç¢ºãªæ å ±ã®æ¡æ£ãé²ãããã®éèŠãªããŒã«ãšãªãåŸãŸãã
ãããã®ã¢ãã«ã®å®äžçãžã®å¿çšã¯ã質åã«çããã ãã§ã¯ãããŸããã ãããã¯ãæ£è æè²ã蚺æããã»ã¹ã®æ¯æŽãããã«ã¯å»åŠçã®ãã¬ãŒãã³ã°ã«ã䜿çšã§ããŸãã ãã ãã人éã«ããé©åãªç£ç£ãªãã« AI ã«äŸåããããšãé¿ããããã«ããã®å°å ¥ã¯æ éã«ç®¡çããå¿ èŠããããŸãã
å»çç¥èãé²åããã«ã€ããŠãLLM ãé©å¿ããŠåŠç¿ããå¿ èŠããããŸãã ããã«ã¯ãç¶ç¶çãªåŠç¿ãšæŽæ°ã®ã¡ã«ããºã ãå¿ èŠã§ãããé·æã«ããã£ãŠã¢ãã«ã®é¢é£æ§ãšæ£ç¢ºæ§ã確ä¿ããŸãã